PT Kalbe Farma Tbk. (PTKFF)

USD 0.08

(0.0%)

Net Debt Summary of PT Kalbe Farma Tbk.

  • PT Kalbe Farma Tbk.'s latest annual net debt in 2023 was -169.7 Million USD , up 4.69% from previous year.
  • PT Kalbe Farma Tbk.'s latest quarterly net debt in 2024 Q2 was -163.15 Million USD , up 23.36% from previous quarter.
  • PT Kalbe Farma Tbk. reported annual net debt of -178.05 Million USD in 2022, up 54.5% from previous year.
  • PT Kalbe Farma Tbk. reported annual net debt of -391.3 Million USD in 2021, down -35.75% from previous year.
  • PT Kalbe Farma Tbk. reported quarterly net debt of -212.87 Million USD for 2024 Q1, down -25.44% from previous quarter.
  • PT Kalbe Farma Tbk. reported quarterly net debt of -163.15 Million USD for 2024 Q2, up 23.36% from previous quarter.

Annual Net Debt Chart of PT Kalbe Farma Tbk. (2023 - 2015)

Historical Annual Net Debt of PT Kalbe Farma Tbk. (2023 - 2015)

Year Net Debt Net Debt Growth
2023 -169.7 Million USD 4.69%
2022 -178.05 Million USD 54.5%
2021 -391.3 Million USD -35.75%
2020 -288.26 Million USD -79.97%
2019 -160.17 Million USD 17.62%
2018 -194.43 Million USD -7.41%
2017 -181.01 Million USD 6.65%
2016 -193.91 Million USD -15.23%
2015 -168.27 Million USD 0.0%

Peer Net Debt Comparison of PT Kalbe Farma Tbk.

Name Net Debt Net Debt Difference
AstraZeneca PLC 22.74 Billion USD 100.746%
Bristol-Myers Squibb Company PFD CONV 2 30 Billion USD 100.566%
CSPC Pharmaceutical Group Limited -1.59 Billion USD 89.354%
Clarus Therapeutics Holdings, Inc. 15.85 Million USD 1170.402%
Novartis AG 12.95 Billion USD 101.31%